The NBS 6 is not cleared by the FDA for commercial use in Chronic Pain in the USA, for investigational use only.

Alleviating chronic neuropathic pain

At Nexstim we are using decades of scientific research to help alleviate drug-resistant brain diseases and disorders. As the world’s leading company combining TMS with 3D brain imaging, we offer a powerful non-invasive technique for the relief of chronic, refractory neuropathic pain.

Treating chronic pain today

Despite recent therapeutic advances, more than half of patients with neuropathic pain still experience unsatisfactory pain control. It is widely believed that modulating neural activity in the motor cortex also modulates pain perception. Targeting rTMS, repetitive TMS, to the motor cortex region has achieved a clinically-meaningful response in a significant proportion of patients with chronic, unilateral neuropathic pain.

Growing and converging evidence suggests that the motor system becomes integrated with the complex processing of nociceptive signals. In patients with amputated limbs, part of the primary motor cortex becomes redundant for its prior tasks, while also being deprived of the sensory feedback. When a critical role of the motor cortex, that of suppressing excessive sensory input into the thalamus and inducing descending pain modulation, is compromised, spontaneous pain may result. 

 

Finnish rTMS patient case

Hear first hand from a patient in the Helsinki University Hospital & Orton pain treatment program, how navigated rTMS changed his live (subtitles are available in English).

 

rTMS offers a truly significant analgesic effect

Target site selection

Stimulation parameters and durability

Pre-surgical rTMS therapy in MCS implantation

Interested in a live demo of nTMS?

Our team of physicians, researchers, and engineers is prepared to answer your questions. If you would like to learn more or set up a virtual demonstration for your team, please contact us!

A large controlled trial showed that individualized navigated rTMS led to sustained improvement of neuropathic pain in 70% of patients who had not benefited from any other therapy.

Turo J. Nurmikko, MD, PhD Professor of Pain Science, Faculty of Health and Life Sciences, University of Liverpool Director, Pain Research Institute, Liverpool Honorary Consultant in Pain Relief, The Walton Centre NHS Foundation Trust, UK.

A large controlled trial showed that individualized navigated rTMS led to sustained improvement of neuropathic pain in 70% of patients who had not benefited from any other therapy.

Turo J. Nurmikko, MD, PhD Professor of Pain Science, Faculty of Health and Life Sciences, University of Liverpool Director, Pain Research Institute, Liverpool Honorary Consultant in Pain Relief, The Walton Centre NHS Foundation Trust, UK.

A large controlled trial showed that individualized navigated rTMS led to sustained improvement of neuropathic pain in 70% of patients who had not benefited from any other therapy.

Turo J. Nurmikko, MD, PhD Professor of Pain Science, Faculty of Health and Life Sciences, University of Liverpool Director, Pain Research Institute, Liverpool Honorary Consultant in Pain Relief, The Walton Centre NHS Foundation Trust, UK.

Yes, I would like to know more

Indications for use (CE mark) and patient safety

References